{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:27:27Z","timestamp":1790710047426,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020594","name":"Israel Institute for Biological Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Francisella tularensis<\/jats:italic> (<jats:italic>Ft<\/jats:italic>), the causative agent of lethal tularemia, is classified as a category A biological warfare threat agent. While <jats:italic>Ft<\/jats:italic> infection is treatable by antibiotics, many failed antibiotic treatments were reported, highlighting the need for effective new treatments. It has been demonstrated that binding of antibody-coated bacteria to the Fc receptor located on phagocytic cells is a key process needed for efficient protection against <jats:italic>Ft<\/jats:italic>. Yet, <jats:italic>Ft<\/jats:italic> utilizes the same receptor to enter the phagocytic cells in order to escape the immune system. To address the question whether an anti-<jats:italic>Ft<\/jats:italic> LPS antibody lacking the ability to bind the Fc receptor may inhibit the entry of <jats:italic>Ft<\/jats:italic> into host cells, a soluble scFv (TL1-scFv) was constructed from an anti <jats:italic>Ft<\/jats:italic>-LPS antibody (TL1) that was isolated from an immune single-chain (scFv) phage-display library. Bacterial uptake was assessed upon infection of macrophages with <jats:italic>Ft<\/jats:italic> live attenuated strain (LVS) in the presence of either TL1 or TL1-scFv. While incubation of LVS in the presence of TL1 greatly enhanced bacterial uptake, LVS uptake was significantly inhibited in the presence of TL1-scFv. These results prompt further experiments probing the therapeutic efficacy of TL1-scFv, alone or in combination with antibiotic treatment.<\/jats:p>","DOI":"10.1038\/s41598-019-47931-w","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T10:22:49Z","timestamp":1565086969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment"],"prefix":"10.1038","volume":"9","author":[{"given":"Adva","family":"Mechaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Mazor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"47931_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrmicro1045","volume":"2","author":"PC Oyston","year":"2004","unstructured":"Oyston, P. C., Sjostedt, A. & Titball, R. W. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2, 967\u2013978, https:\/\/doi.org\/10.1038\/nrmicro1045 (2004).","journal-title":"Nat Rev Microbiol"},{"key":"47931_CR2","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","volume":"285","author":"DT Dennis","year":"2001","unstructured":"Dennis, D. T. et al. Tularemia as a biological weapon: medical and public health management. JAMA 285, 2763\u20132773 (2001).","journal-title":"JAMA"},{"key":"47931_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fcimb.2017.00122","volume":"7","author":"Y Caspar","year":"2017","unstructured":"Caspar, Y. & Maurin, M. Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models. Front Cell Infect Microbiol 7, 122, https:\/\/doi.org\/10.3389\/fcimb.2017.00122 (2017).","journal-title":"Front Cell Infect Microbiol"},{"key":"47931_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/mmi.12004","volume":"86","author":"AC Llewellyn","year":"2012","unstructured":"Llewellyn, A. C. et al. NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis. Mol Microbiol 86, 611\u2013627, https:\/\/doi.org\/10.1111\/mmi.12004 (2012).","journal-title":"Mol Microbiol"},{"key":"47931_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/00365548.2013.796089","volume":"45","author":"M Kosker","year":"2013","unstructured":"Kosker, M. et al. A case of oculoglandular tularemia resistant to medical treatment. Scand J Infect Dis 45, 725\u2013727, https:\/\/doi.org\/10.3109\/00365548.2013.796089 (2013).","journal-title":"Scand J Infect Dis"},{"key":"47931_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1086\/322601","volume":"33","author":"JL Perez-Castrillon","year":"2001","unstructured":"Perez-Castrillon, J. L., Bachiller-Luque, P., Martin-Luquero, M., Mena-Martin, F. J. & Herreros, V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis 33, 573\u2013576, https:\/\/doi.org\/10.1086\/322601 (2001).","journal-title":"Clin Infect Dis"},{"key":"47931_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00005792-198507000-00006","volume":"64","author":"ME Evans","year":"1985","unstructured":"Evans, M. E., Gregory, D. W., Schaffner, W. & McGee, Z. A. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 64, 251\u2013269 (1985).","journal-title":"Medicine (Baltimore)"},{"key":"47931_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fcimb.2014.00040","volume":"4","author":"S Boisset","year":"2014","unstructured":"Boisset, S., Caspar, Y., Sutera, V. & Maurin, M. New therapeutic approaches for treatment of tularaemia: a review. Front Cell Infect Microbiol 4, 40, https:\/\/doi.org\/10.3389\/fcimb.2014.00040 (2014).","journal-title":"Front Cell Infect Microbiol"},{"key":"47931_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4049\/jimmunol.179.1.532","volume":"179","author":"GS Kirimanjeswara","year":"2007","unstructured":"Kirimanjeswara, G. S., Golden, J. M., Bakshi, C. S. & Metzger, D. W. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol 179, 532\u2013539 (2007).","journal-title":"J Immunol"},{"key":"47931_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-065X.2008.00689.x","volume":"225","author":"GS Kirimanjeswara","year":"2008","unstructured":"Kirimanjeswara, G. S., Olmos, S., Bakshi, C. S. & Metzger, D. W. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol Rev 225, 244\u2013255, https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00689.x (2008).","journal-title":"Immunol Rev"},{"key":"47931_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/CVI.00362-08","volume":"16","author":"AG Savitt","year":"2009","unstructured":"Savitt, A. G., Mena-Taboada, P., Monsalve, G. & Benach, J. L. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy. Clin Vaccine Immunol 16, 414\u2013422, https:\/\/doi.org\/10.1128\/CVI.00362-08 (2009).","journal-title":"Clin Vaccine Immunol"},{"key":"47931_CR12","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1128\/IAI.00795-06","volume":"74","author":"A Balagopal","year":"2006","unstructured":"Balagopal, A. et al. Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 74, 5114\u20135125, https:\/\/doi.org\/10.1128\/IAI.00795-06 (2006).","journal-title":"Infect Immun"},{"key":"47931_CR13","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1128\/IAI.73.9.5892-5902.2005","volume":"73","author":"DL Clemens","year":"2005","unstructured":"Clemens, D. L., Lee, B. Y. & Horwitz, M. A. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun 73, 5892\u20135902, https:\/\/doi.org\/10.1128\/IAI.73.9.5892-5902.2005 (2005).","journal-title":"Infect Immun"},{"key":"47931_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fcimb.2017.00446","volume":"7","author":"Z Krocova","year":"2017","unstructured":"Krocova, Z., Macela, A. & Kubelkova, K. Innate Immune Recognition: Implications for the Interaction of Francisella tularensis with the Host Immune System. Front Cell Infect Microbiol 7, 446, https:\/\/doi.org\/10.3389\/fcimb.2017.00446 (2017).","journal-title":"Front Cell Infect Microbiol"},{"key":"47931_CR15","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1462-5822.2006.00719.x","volume":"8","author":"LM Pierini","year":"2006","unstructured":"Pierini, L. M. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell Microbiol 8, 1361\u20131370, https:\/\/doi.org\/10.1111\/j.1462-5822.2006.00719.x (2006).","journal-title":"Cell Microbiol"},{"key":"47931_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1189\/jlb.2A1215-555RR","volume":"100","author":"EB Duffy","year":"2016","unstructured":"Duffy, E. B., Periasamy, S., Hunt, D., Drake, J. R. & Harton, J. A. FcgammaR mediates TLR2- and Syk-dependent NLRP3 inflammasome activation by inactivated Francisella tularensis LVS immune complexes. J Leukoc Biol 100, 1335\u20131347, https:\/\/doi.org\/10.1189\/jlb.2A1215-555RR (2016).","journal-title":"J Leukoc Biol"},{"key":"47931_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1128\/IAI.02289-14","volume":"83","author":"C Bitsaktsis","year":"2015","unstructured":"Bitsaktsis, C., Babadjanova, Z. & Gosselin, E. J. In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model. Infect Immun 83, 77\u201389, https:\/\/doi.org\/10.1128\/IAI.02289-14 (2015).","journal-title":"Infect Immun"},{"key":"47931_CR18","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1128\/IAI.01382-10","volume":"79","author":"H Geier","year":"2011","unstructured":"Geier, H. & Celli, J. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect Immun 79, 2204\u20132214, https:\/\/doi.org\/10.1128\/IAI.01382-10 (2011).","journal-title":"Infect Immun"},{"issue":"2","key":"47931_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/toxins10020080","volume":"10","author":"Adva Mechaly","year":"2018","unstructured":"Mechaly, A. et al. Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication. Toxins (Basel) 10, https:\/\/doi.org\/10.3390\/toxins10020080 (2018).","journal-title":"Toxins"},{"issue":"3","key":"47931_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/toxins8030064","volume":"8","author":"Tal Noy-Porat","year":"2016","unstructured":"Noy-Porat, T. et al. Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates. Toxins (Basel) 8, https:\/\/doi.org\/10.3390\/toxins8030064 (2016).","journal-title":"Toxins"},{"key":"47931_CR21","doi-asserted-by":"publisher","first-page":"e24654","DOI":"10.1371\/journal.pone.0024654","volume":"6","author":"DS Reed","year":"2011","unstructured":"Reed, D. S. et al. Pneumonic tularemia in rabbits resembles the human disease as illustrated by radiographic and hematological changes after infection. PLoS One 6, e24654, https:\/\/doi.org\/10.1371\/journal.pone.0024654 (2011).","journal-title":"PLoS One"},{"key":"47931_CR22","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1128\/IAI.01498-14","volume":"82","author":"DS Reed","year":"2014","unstructured":"Reed, D. S. et al. Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain. Infect Immun 82, 2098\u20132105, https:\/\/doi.org\/10.1128\/IAI.01498-14 (2014).","journal-title":"Infect Immun"},{"issue":"7","key":"47931_CR23","doi-asserted-by":"publisher","first-page":"ftw079","DOI":"10.1093\/femspd\/ftw079","volume":"74","author":"Elizabeth Stinson","year":"2016","unstructured":"Stinson, E., Smith, L. P., Cole, K. S., Barry, E. M. & Reed, D. S. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model. Pathog Dis 74, https:\/\/doi.org\/10.1093\/femspd\/ftw079 (2016).","journal-title":"Pathogens and Disease"},{"key":"47931_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00284-017-1217-y","volume":"74","author":"R Gaur","year":"2017","unstructured":"Gaur, R., Alam, S. I. & Kamboj, D. V. Immunoproteomic Analysis of Antibody Response of Rabbit Host Against Heat-Killed Francisella tularensis Live Vaccine Strain. Curr Microbiol 74, 499\u2013507, https:\/\/doi.org\/10.1007\/s00284-017-1217-y (2017).","journal-title":"Curr Microbiol"},{"key":"47931_CR25","doi-asserted-by":"publisher","first-page":"e0205928","DOI":"10.1371\/journal.pone.0205928","volume":"13","author":"KJ O\u2019Malley","year":"2018","unstructured":"O\u2019Malley, K. J. et al. Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis. PLoS One 13, e0205928, https:\/\/doi.org\/10.1371\/journal.pone.0205928 (2018).","journal-title":"PLoS One"},{"key":"47931_CR26","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.vaccine.2008.01.005","volume":"26","author":"MF Pasetti","year":"2008","unstructured":"Pasetti, M. F. et al. An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes. Vaccine 26, 1773\u20131785, https:\/\/doi.org\/10.1016\/j.vaccine.2008.01.005 (2008).","journal-title":"Vaccine"},{"key":"47931_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1365-2958.1996.tb02524.x","volume":"20","author":"SC Cowley","year":"1996","unstructured":"Cowley, S. C., Myltseva, S. V. & Nano, F. E. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol Microbiol 20, 867\u2013874 (1996).","journal-title":"Mol Microbiol"},{"key":"47931_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fmicb.2010.00129","volume":"1","author":"S Soni","year":"2010","unstructured":"Soni, S. et al. Francisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide o-antigen, core and lipid a and affects intramacrophage survival and vaccine efficacy. Front Microbiol 1, 129, https:\/\/doi.org\/10.3389\/fmicb.2010.00129 (2010).","journal-title":"Front Microbiol"},{"key":"47931_CR29","doi-asserted-by":"publisher","first-page":"e6351","DOI":"10.1371\/journal.pone.0006351","volume":"4","author":"R Rosenfeld","year":"2009","unstructured":"Rosenfeld, R. et al. Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection. PLoS One 4, e6351, https:\/\/doi.org\/10.1371\/journal.pone.0006351 (2009).","journal-title":"PLoS One"},{"key":"47931_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hyb.2010.0083","volume":"30","author":"MI Roche","year":"2011","unstructured":"Roche, M. I., Lu, Z., Hui, J. H. & Sharon, J. Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide. Hybridoma (Larchmt) 30, 19\u201328, https:\/\/doi.org\/10.1089\/hyb.2010.0083 (2011).","journal-title":"Hybridoma (Larchmt)"},{"key":"47931_CR31","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1128\/AAC.01104-12","volume":"56","author":"S Rotem","year":"2012","unstructured":"Rotem, S. et al. Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection. Antimicrob Agents Chemother 56, 5406\u20135408, https:\/\/doi.org\/10.1128\/AAC.01104-12 (2012).","journal-title":"Antimicrob Agents Chemother"},{"key":"47931_CR32","doi-asserted-by":"publisher","first-page":"9394","DOI":"10.1021\/ac501840g","volume":"86","author":"E Durighello","year":"2014","unstructured":"Durighello, E., Bellanger, L., Ezan, E. & Armengaud, J. Proteogenomic biomarkers for identification of Francisella species and subspecies by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Anal Chem 86, 9394\u20139398, https:\/\/doi.org\/10.1021\/ac501840g (2014).","journal-title":"Anal Chem"},{"key":"47931_CR33","doi-asserted-by":"publisher","first-page":"e114622","DOI":"10.1371\/journal.pone.0114622","volume":"9","author":"EA Lamont","year":"2014","unstructured":"Lamont, E. A. et al. A combined enrichment and aptamer pulldown assay for Francisella tularensis detection in food and environmental matrices. PLoS One 9, e114622, https:\/\/doi.org\/10.1371\/journal.pone.0114622 (2014).","journal-title":"PLoS One"},{"key":"47931_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bios.2014.08.038","volume":"64","author":"SH Seo","year":"2015","unstructured":"Seo, S. H. et al. Highly sensitive detection of a bio-threat pathogen by gold nanoparticle-based oligonucleotide-linked immunosorbent assay. Biosens Bioelectron 64, 69\u201373, https:\/\/doi.org\/10.1016\/j.bios.2014.08.038 (2015).","journal-title":"Biosens Bioelectron"},{"key":"47931_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ab.2016.04.018","volume":"506","author":"A Mechaly","year":"2016","unstructured":"Mechaly, A., Cohen, H., Cohen, O. & Mazor, O. A biolayer interferometry-based assay for rapid and highly sensitive detection of biowarfare agents. Anal Biochem 506, 22\u201327, https:\/\/doi.org\/10.1016\/j.ab.2016.04.018 (2016).","journal-title":"Anal Biochem"},{"key":"47931_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/lam.12392","volume":"60","author":"AA Zasada","year":"2015","unstructured":"Zasada, A. A., Forminska, K., Zacharczuk, K., Jacob, D. & Grunow, R. Comparison of eleven commercially available rapid tests for detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis. Lett Appl Microbiol 60, 409\u2013413, https:\/\/doi.org\/10.1111\/lam.12392 (2015).","journal-title":"Lett Appl Microbiol"},{"key":"47931_CR37","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1016\/S0264-410X(01)00189-X","volume":"19","author":"M Fulop","year":"2001","unstructured":"Fulop, M., Mastroeni, P., Green, M. & Titball, R. W. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19, 4465\u20134472 (2001).","journal-title":"Vaccine"},{"key":"47931_CR38","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1128\/IAI.00605-10","volume":"79","author":"G Mara-Koosham","year":"2011","unstructured":"Mara-Koosham, G., Hutt, J. A., Lyons, C. R. & Wu, T. H. Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains. Infect Immun 79, 1770\u20131778, https:\/\/doi.org\/10.1128\/IAI.00605-10 (2011).","journal-title":"Infect Immun"},{"key":"47931_CR39","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1128\/IAI.01429-06","volume":"75","author":"C Raynaud","year":"2007","unstructured":"Raynaud, C. et al. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect Immun 75, 536\u2013541, https:\/\/doi.org\/10.1128\/IAI.01429-06 (2007).","journal-title":"Infect Immun"},{"key":"47931_CR40","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1016\/j.vaccine.2014.07.050","volume":"32","author":"GH Pham","year":"2014","unstructured":"Pham, G. H., Iglesias, B. V. & Gosselin, E. J. Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells. Vaccine 32, 5212\u20135220, https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.050 (2014).","journal-title":"Vaccine"},{"key":"47931_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/JIR.S121233","volume":"9","author":"JM Hayes","year":"2016","unstructured":"Hayes, J. M., Wormald, M. R., Rudd, P. M. & Davey, G. P. Fc gamma receptors: glycobiology and therapeutic prospects. J Inflamm Res 9, 209\u2013219, https:\/\/doi.org\/10.2147\/JIR.S121233 (2016).","journal-title":"J Inflamm Res"},{"key":"47931_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/19420862.2015.1111497","volume":"8","author":"Z Li","year":"2016","unstructured":"Li, Z. et al. Influence of molecular size on tissue distribution of antibody fragments. MAbs 8, 113\u2013119, https:\/\/doi.org\/10.1080\/19420862.2015.1111497 (2016).","journal-title":"MAbs"},{"key":"47931_CR43","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1016\/j.vaccine.2017.10.053","volume":"35","author":"L Bar-On","year":"2017","unstructured":"Bar-On, L. et al. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung. Vaccine 35, 7001\u20137009, https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.053 (2017).","journal-title":"Vaccine"},{"key":"47931_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.plasmid.2010.07.001","volume":"64","author":"XR Bina","year":"2010","unstructured":"Bina, X. R., Miller, M. A. & Bina, J. E. Construction of a bioluminescence reporter plasmid for Francisella tularensis. Plasmid 64, 156\u2013161, https:\/\/doi.org\/10.1016\/j.plasmid.2010.07.001 (2010).","journal-title":"Plasmid"},{"key":"47931_CR45","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1128\/AEM.01862-10","volume":"77","author":"G Zaide","year":"2011","unstructured":"Zaide, G. et al. Identification and characterization of novel and potent transcription promoters of Francisella tularensis. Appl Environ Microbiol 77, 1608\u20131618, https:\/\/doi.org\/10.1128\/AEM.01862-10 (2011).","journal-title":"Appl Environ Microbiol"},{"key":"47931_CR46","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1128\/IAI.72.9.5340-5348.2004","volume":"72","author":"NJ Phillips","year":"2004","unstructured":"Phillips, N. J., Schilling, B., McLendon, M. K., Apicella, M. A. & Gibson, B. W. Novel modification of lipid A of Francisella tularensis. Infect Immun 72, 5340\u20135348, https:\/\/doi.org\/10.1128\/IAI.72.9.5340-5348.2004 (2004).","journal-title":"Infect Immun"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47931-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47931-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47931-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:21:57Z","timestamp":1671279717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-47931-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["47931"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-47931-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M., O.C. and O.M. are listed as inventors on a patent application (IL260412) filed by the Israel Institute for Biological Research for using antibody TL1 in detection and treatment of <i>Ft<\/i> infection. TL1 antibody is now available for purchase from Sigma-Aldrich.\u00a0All other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11418"}}